Gerry Muhle

Gerry Muhle possesses extensive experience in the pharmaceutical and biotechnology sectors, currently serving as SVP & Head of Global Product Strategy at Galderma since October 2021, overseeing all global business units and brand strategy. Prior roles include leadership positions at AbbVie, notably as SVP for the Aesthetics and Prescriptions Global Business Units, and VP of International Strategic Marketing for Allergan Aesthetics. Additional significant roles at Allergan and GlaxoSmithKline highlight a strong track record in commercial strategy development and operational leadership across various therapeutic areas, including aesthetic and cardiovascular markets. Gerry's educational background features degrees in Biochemistry and Molecular Biology, along with certifications in digital marketing and strategic leadership from prestigious institutions.